These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

909 related items for PubMed ID: 25889427

  • 1. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK, Nada R, Kumar A, Ramachandran R, Rayat CS, Jha V, Sakhuja V, Joshi K.
    Diagn Pathol; 2015 Mar 17; 10():6. PubMed ID: 25889427
    [Abstract] [Full Text] [Related]

  • 2. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y, Ishikura K, Hamada R, Harada R, Sakai T, Hamasaki Y, Hataya H, Fukuzawa R, Ogata K, Honda M.
    Nephrology (Carlton); 2015 Apr 17; 20(4):286-92. PubMed ID: 25524631
    [Abstract] [Full Text] [Related]

  • 3. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
    Medjeral-Thomas NR, O'Shaughnessy MM, O'Regan JA, Traynor C, Flanagan M, Wong L, Teoh CW, Awan A, Waldron M, Cairns T, O'Kelly P, Dorman AM, Pickering MC, Conlon PJ, Cook HT.
    Clin J Am Soc Nephrol; 2014 Jan 17; 9(1):46-53. PubMed ID: 24178974
    [Abstract] [Full Text] [Related]

  • 4. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB.
    Kidney Int; 2018 Apr 17; 93(4):977-985. PubMed ID: 29310824
    [Abstract] [Full Text] [Related]

  • 5. C3 glomerulonephritis with a severe crescentic phenotype.
    Ravindran A, Fervenza FC, Smith RJH, Sethi S.
    Pediatr Nephrol; 2017 Sep 17; 32(9):1625-1633. PubMed ID: 28593446
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological features of C3 glomerulopathy in children: a single-center experience.
    Drake KA, Ellington N, Gattineni J, Torrealba JR, Hendricks AR.
    Pediatr Nephrol; 2020 Jan 17; 35(1):153-162. PubMed ID: 31667615
    [Abstract] [Full Text] [Related]

  • 7. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children.
    Ueda C, Horinouchi T, Inoki Y, Ichikawa Y, Tanaka Y, Kitakado H, Kondo A, Sakakibara N, Nagano C, Yamamura T, Fujimura J, Kamiyoshi N, Ishimori S, Ninchoji T, Kaito H, Shima Y, Iijima K, Nozu K, Yoshikawa N.
    Pediatr Nephrol; 2024 Sep 17; 39(9):2679-2689. PubMed ID: 38662234
    [Abstract] [Full Text] [Related]

  • 8. C3 glomerulopathy.
    Servais A, Noël LH, Frémeaux-Bacchi V, Lesavre P.
    Contrib Nephrol; 2013 Sep 17; 181():185-93. PubMed ID: 23689580
    [Abstract] [Full Text] [Related]

  • 9. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
    Kersnik Levart T, Ferluga D, Vizjak A, Mraz J, Kojc N.
    Diagn Pathol; 2016 Oct 07; 11(1):94. PubMed ID: 27717365
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy.
    Madden B, Singh RD, Haas M, Palma LMP, Sharma A, Vargas MJ, Gross L, Negron V, Nate T, Charlesworth MC, Theis JD, Nasr SH, Nath KA, Fervenza FC, Sethi S.
    Kidney Int; 2024 May 07; 105(5):1077-1087. PubMed ID: 38447879
    [Abstract] [Full Text] [Related]

  • 11. Toward a working definition of C3 glomerulopathy by immunofluorescence.
    Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD.
    Kidney Int; 2014 Feb 07; 85(2):450-6. PubMed ID: 24067430
    [Abstract] [Full Text] [Related]

  • 12. De novo C3 glomerulonephritis in a renal allograft.
    Nahm JH, Song SH, Kim YS, Cheong HI, Lim BJ, Kim BS, Jeong HJ.
    Ultrastruct Pathol; 2016 Feb 07; 40(2):112-5. PubMed ID: 26986539
    [Abstract] [Full Text] [Related]

  • 13. C3 glomerulopathy and current dilemmas.
    Ito N, Ohashi R, Nagata M.
    Clin Exp Nephrol; 2017 Aug 07; 21(4):541-551. PubMed ID: 27878657
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneous histologic and clinical evolution in 3 cases of dense deposit disease with long-term follow-up.
    Figuères ML, Frémeaux-Bacchi V, Rabant M, Galmiche L, Marinozzi MC, Grünfeld JP, Noël LH, Servais A.
    Hum Pathol; 2014 Nov 07; 45(11):2326-33. PubMed ID: 25260719
    [Abstract] [Full Text] [Related]

  • 15. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.
    Kidney Int; 2012 Aug 07; 82(4):465-73. PubMed ID: 22673887
    [Abstract] [Full Text] [Related]

  • 16. Defining the complement biomarker profile of C3 glomerulopathy.
    Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ.
    Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1876-82. PubMed ID: 25341722
    [Abstract] [Full Text] [Related]

  • 17. Morphological and etiological analyses of C3 and non-C3 glomerulonephritis in primary membranoproliferative glomerulonephritis using periodic acid-methenamine silver stain electron microscopy: a retrospective multicentered study.
    Honma S, Sato N, Sakaguchi R, Hashiguchi A, Uesugi N, Nakamura Y, Sasano H, Joh K.
    Med Mol Morphol; 2024 Mar 07; 57(1):23-34. PubMed ID: 37823929
    [Abstract] [Full Text] [Related]

  • 18. Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.
    Ali A, Schlanger L, Nasr SH, Sethi S, Gorbatkin SM.
    Am J Kidney Dis; 2016 Mar 07; 67(3):479-82. PubMed ID: 26704376
    [Abstract] [Full Text] [Related]

  • 19. C3 glomerulopathy in children: Is there still a place for anti-cellular immunosuppression?
    Kojc N, Bahovec A, Levart TK.
    Nephrology (Carlton); 2019 Feb 07; 24(2):188-194. PubMed ID: 30393898
    [Abstract] [Full Text] [Related]

  • 20. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.
    J Med Genet; 2007 Mar 07; 44(3):193-9. PubMed ID: 17018561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.